Bank of New York Mellon Corp

Bank

Position in CRVS — Corvus Pharmaceuticals, Inc.

CIK 1390777 NEW YORK, NY

Position in CRVS

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$3,026,977

+$315,353 QoQ

Shares Held

202,609

+9.3% QoQ

Ownership

0.241%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#47

of 172 holders

Holding Since

Jun 2023

8 quarters on record

Voting authority Sole 82% Shared 0% None 18%

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. CRVS ranks #124 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,672,623	$830,842,010
2	REGN	Regeneron Pharmaceuticals, Inc.	758,492	$472,950,091
3	JAZZ	Jazz Pharmaceuticals plc	1,578,013	$380,253,782
4	ALNY	Alnylam Pharmaceuticals, Inc.	492,071	$148,128,128
5	INSM	INSMED Inc	1,312,756	$139,966,036
6	MRNA	Moderna, Inc.	1,701,675	$119,168,293
7	RVMD	Revolution Medicines, Inc.	601,056	$112,565,759
8	INCY	Incyte Corp	972,825	$110,279,435

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,026,977	202,609	+9.3%	Shares	Defined	2026-08-06
2026-03-31	$2,711,624	185,347	+40.8%	Shares	Defined	2026-05-05
2025-12-31	$1,013,534	131,628	+4.0%	Shares	Defined	2026-02-10
2025-09-30	$932,510	126,528	+14.3%	Shares	Defined	2025-11-03
2025-06-30	$442,752	110,688	+421.6%	Shares	Defined	2025-08-05
2023-12-31	$37,345	21,219	0.0%	Shares	Defined	2024-01-29
2023-09-30	$30,979	21,219	0.0%	Shares	Defined	2023-10-24
2023-06-30	$48,591	21,219	—	Shares	Defined	2023-08-03
No filing history on record for this holder in this stock.